Jensen Investment Management significantly increased its investment in veterinary diagnostics leader IDEXX Laboratories (IDXX), according to a recent quarterly disclosure filed with the SEC. The filing, which reflects trades made during the second quarter of 2026, revealed the firm's holdings jumped from 3,570 shares to 105,710 shares, an increase of over 2,800%. The total reported value of the position grew from approximately $2.01 million to $55.65 million.
Public statements from the firm confirm the new position was added to its Quality Growth Strategy. In its second-quarter commentary, Jensen noted that weaker share performance for IDEXX earlier in 2026 provided an attractive entry point. The investment manager cited IDEXX's strong business fundamentals, high customer retention, and recurring revenue streams as key drivers for the decision. As with all 13F filings, these disclosed positions reflect a specific point in time and may have changed since the reporting period ended.